title: [Two cases of ocular damage associated with proton pump inhibitors].
authors.affiliation: First Department of Internal Medicine, Matsue City Hospital.
authors.forename: M
authors.initials: M
authors.lastname: Kohno
authors.forename: M
authors.initials: M
authors.lastname: Yamada
authors.forename: T
authors.initials: T
authors.lastname: Okumura
authors.forename: K
authors.initials: K
authors.lastname: Hori
authors.forename: U
authors.initials: U
authors.lastname: Hoshino
authors.forename: T
authors.initials: T
authors.lastname: Yoshimura
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D005260:Female; D006801:Humans; D064747:Lansoprazole; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects / Q000031:analogs & derivatives*; D054328:Proton Pump Inhibitors; D064750:Rabeprazole; D014786:Vision Disorders / Q000139:chemically induced*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D064750:Rabeprazole; D009853:Omeprazole